Snowdon wins $500K grant for parasitic disease
Snowdon, a New Brunswick, N.J., drug developer, received a $500,000 grant from the New Jersey Commission on Science & Technology. The grant matches $500,000 the company raised in March from the Foundation Venture Capital Group.
Snowdon is developing new treatments against cancer, pain and infectious parasitic diseases.
Next Story: Ceregene: Catching an updraft in gene therapy
Previous Story: Immunotope raises $350K for cancer vaccine
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
